WP
EW icon

WealthShield Partners’s Edwards Lifesciences EW Stock Holding History

WealthShield Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
28,111
+926
+3% +$77.6K 0.39% 75
2026
Q1 		$2.18M Buy
27,185
+553
+2% +$45.6K 0.24% 118
2025
Q4 		$2.27M Buy
26,632
+851
+3% +$69.8K 0.25% 108
2025
Q3 		$2M Buy
25,781
+439
+2% +$34.3K 0.23% 118
2025
Q2 		$1.98M Buy
+25,342
New +$1.89M 0.24% 119
2023
Q3 		– Sell
-20,312
Closed -$1.92M – 490
2023
Q2 		$1.92M Sell
20,312
-4,209
-17% -$366K 0.29% 95
2023
Q1 		$2.03M Buy
+24,521
New +$1.93M 0.33% 79
2022
Q4 		– Sell
-16,191
Closed -$1.34M – 297
2022
Q3 		$1.34M Buy
16,191
+1,180
+8% +$114K 0.27% 99
2022
Q2 		$1.43M Buy
15,011
+1,151
+8% +$119K 0.28% 87
2022
Q1 		$1.63M Buy
13,860
+2,010
+17% +$225K 0.26% 89
2021
Q4 		$1.53M Buy
11,850
+1,950
+20% +$227K 0.26% 85
2021
Q3 		$1.12M Buy
9,900
+9,451
+2,105% +$1.08M 0.3% 73
2021
Q2 		$47K Buy
+449
New +$42.3K 0.01% 485
2021
Q1 		– Sell
-5,205
Closed -$474K – 1149
2020
Q4 		$474K Buy
5,205
+910
+21% +$75.5K 0.09% 178
2020
Q3 		$343K Buy
+4,295
New +$335K 0.12% 176

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

WealthShield Partners's EW Position: Q2 2026 in Review

WealthShield Partners increased its Edwards Lifesciences (EW) stake by 3.4% in Q2 2026, buying an estimated $77.6K and bringing the position to 28,111 shares worth $2.54M. The position accounts for 0.39% of the portfolio, ranked #75.

WealthShield Partners first reported a position in EW in Q3 2020 and has held it in 15 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • WealthShield Partners held 28,111 shares of Edwards Lifesciences worth $2.54M as of Q2 2026.
  • WealthShield Partners bought 926 Edwards Lifesciences shares in Q2 2026, an estimated $77.6K.
  • Edwards Lifesciences made up 0.39% of WealthShield Partners's portfolio in Q2 2026, its #75 holding.
  • WealthShield Partners first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 15 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.